Luis I. García

Dr. Luis I. García

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2022 in NeuroSci
Verified
Journal Article
Open access
PDF file
SLSandra Yasbeth Lara
Sandra Yasbeth Lara
ÁFÁngel de Jesús Laureani Fierro
Ángel de Jesús Laureani Fierro
GAGonzalo Aranda-Abreu
Gonzalo Aranda-Abreu
María Rebeca Toledo-CardenasMaría Rebeca Toledo-Cardenas
María Rebeca Toledo-Cardenas
Luis I. GarcíaLuis I. García
Luis I. García
CECESAR ANTONIO PEREZ ESTUDILLO
CESAR ANTONIO PEREZ ESTUDILLO
For years, the biochemical processes that are triggered by harmful and non-harmful stimuli at the central nervous system level have been extensively studied by the scientific community through numerous techniques and animal models. For example, one of these techniques is the use of immediate expression genes, which is a useful, accessible, and reliable method for observing and quantifying cell activation. It has been shown that both the c-fos gene and its protein c-Fos have rapid activation after stimulus, with the length of time that they remain active depending on the type of stimulus and the activation time depending on the stimulus and the structure studied. Fos requires the participation of other genes (such as c-jun) for its expression (during hetero-dimer forming). c-Fos dimerizes with c-Jun protein to form factor AP-1, which promotes the transcription of various genes. The production and removal of c-Fos is part of cellular homeostasis, but its overexpression results in increased cell proliferation. Although Fos has been used as a marker of cellular activity since the 1990s, which molecular mechanism participates in the regulation of the expression of this protein is still unknown because the gene and the protein are not specific to neurons or glial cells. For these reasons, this work has the objective of gathering information about this protein and its use in neuroscience.

1 June 2014 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
Genaro Alfonso Coria-AvilaGenaro Alfonso Coria-Avila
Genaro Alfonso Coria-Avila
Jorge ManzoJorge Manzo
Jorge Manzo
Luis I. GarcíaLuis I. García
Luis I. García
PCPorfirio Carrillo
Porfirio Carrillo
MMMarta Miquel
Marta Miquel
JPJames G. Pfaus, PhD
James G. Pfaus, PhD

1 January 2009 in Current Drug Abuse Reviews
Verified
Journal Article
Closed access
MMMarta Miquel
Marta Miquel
RTRebeca Toledo
Rebeca Toledo
Luis I. GarcíaLuis I. García
Luis I. García
Genaro Alfonso Coria-AvilaGenaro Alfonso Coria-Avila
Genaro Alfonso Coria-Avila
Jorge ManzoJorge Manzo
Jorge Manzo
Increasing evidence has involved the cerebellum in functions beyond the sphere of motor control. In the present article, we review evidence that involves the cerebellum in addictive behaviour. We aimed on molecular and cellular targets in the cerebellum where addictive drugs can act and induce mechanisms of neuroplasticity that may contribute to the development of an addictive pattern of behaviour. Also, we analyzed the behavioural consequences of repetitive drug administration that result from activity-dependent changes in the efficacy of cerebellar synapses. Revised research involves the cerebellum in drug-induced long-term memory, drug-induced sensitization and the perseverative behavioural phenotype. Results agree to relevant participation of the cerebellum in the functional systems underlying drug addiction. The molecular and cellular actions of addictive drugs in the cerebellum involve long-term adaptative changes in receptors, neurotransmitters and intracellular signalling transduction pathways that may lead to the re-organization of cerebellar microzones and in turn to functional networks where the cerebellum is an important nodal structure. We propose that drug induced activity-dependent synaptic changes in the cerebellum are crucial to the transition from a pattern of recreational drug taking to the compulsive behavioural phenotype. Functional and structural modifications produced by drugs in the cerebellum may enhance the susceptibility of fronto-cerebellar circuitry to be changed by repeated drug exposure. As a part of this functional reorganization, drug-induced cerebellar hyper-responsiveness appears to be central to reducing the influence of executive control of the prefrontal cortex on behaviour and aiding the transition to an automatic mode of control.

1 July 1997 in Brain Research
Verified
Journal Article
Closed access
PPPablo Pacheco
Pablo Pacheco
MCMiguel Angel Camacho
Miguel Angel Camacho
Luis I. GarcíaLuis I. García
Luis I. García
MHMaria Elena Hernandez-Aguilar
Maria Elena Hernandez-Aguilar
PCPorfirio Carrillo
Porfirio Carrillo
Jorge ManzoJorge Manzo
Jorge Manzo

Verified
Journal Article
Open access
PDF file
CRCARLOS CASTILLO RANGEL
CARLOS CASTILLO RANGEL
Gerardo MarínGerardo Marín
Gerardo Marín
KHKarla Aketzalli Hernández-Contreras
Karla Aketzalli Hernández-Contreras
MVMicheel Merari Vichi-Ramirez
Micheel Merari Vichi-Ramirez
Cristofer Zarate-CalderonCristofer Zarate-Calderon
Cristofer Zarate-Calderon
Luis I. GarcíaLuis I. García
Luis I. García
Parkinson’s disease is a neurodegenerative disease whose progression and clinical characteristics have a close bidirectional and multilevel relationship with the process of neuroinflammation. In this context, it is necessary to understand the mechanisms involved in this neuroinflammation–PD link. This systematic search was, hereby, conducted with a focus on the four levels where alterations associated with neuroinflammation in PD have been described (genetic, cellular, histopathological and clinical-behavioral) by consulting the PubMed, Google Scholar, Scielo and Redalyc search engines, including clinical studies, review articles, book chapters and case studies. Initially, 585,772 articles were included, and, after applying the inclusion and exclusion criteria, 84 articles were obtained that contained information about the multilevel association of neuroinflammation with alterations in gene, molecular, cellular, tissue and neuroanatomical expression as well as clinical-behavioral manifestations in PD.

1 January 2008 in Physiology & Behavior
Verified
Journal Article
Closed access
Jorge ManzoJorge Manzo
Jorge Manzo
MMMarta Miquel
Marta Miquel
RTRebeca Toledo
Rebeca Toledo
JMJusto Abraham Mayor-Mar
Justo Abraham Mayor-Mar
Luis I. GarcíaLuis I. García
Luis I. García
MHMaria Elena Hernandez-Aguilar
Maria Elena Hernandez-Aguilar